0
USD ▼
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Bioconjugation Market by Bioconjugation Type, Offering, Technique, Type, End User, Applications, Therapeutic Areas - Global Forecast to 2030- Product Image
Bioconjugation Market by Bioconjugation Type, Offering, Technique, Type, End User, Applications, Therapeutic Areas - Global Forecast to 2030- Product Image
Sale

Bioconjugation Market by Bioconjugation Type, Offering, Technique, Type, End User, Applications, Therapeutic Areas - Global Forecast to 2030

  • PDF Icon

    Report

  • 189 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6083776
UP TO EUR$697USDGBP OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The bioconjugation market is undergoing a transformation as advancements in molecular linkage techniques and shifts in global supply chains reshape competitive strategies. Senior decision-makers now face an ecosystem where scientific innovation directly converges with evolving commercial requirements and regulatory environments.

Market Snapshot: Bioconjugation Market Size and Growth

The bioconjugation market grew from USD 9.06 billion in 2024 to USD 10.12 billion in 2025. It is projected to continue its upward trajectory with a CAGR of 12.31%, reaching USD 18.20 billion by 2030. Growing global demand for advanced therapeutics and precision diagnostics, coupled with ongoing innovation in linker chemistry and analytical techniques, drives this significant expansion. Investment in flexible manufacturing and technology-driven processes is integral as sector participants adapt to changing regulatory climates and trade conditions.

Scope & Segmentation

  • Bioconjugation Types: Oligonucleotide bioconjugation (double-stranded, single-stranded), peptide, polymer, and protein bioconjugates, each supporting distinct therapeutic and research needs.
  • Offerings: Reagents and kits, as well as a broad range of services—including ADC process development, analytical development, drug substance manufacturing, early development bioconjugate services, payload and linker manufacturing, and targeting agent or carrier protein services.
  • Techniques: Amide bond formation, bio-orthogonal reactions, click chemistry, enzymatic methods, and thiol-maleimide coupling, enabling unique application areas.
  • Types: Natural and synthetic bioconjugates, catering to varied design and regulatory preferences.
  • End Users: Academic & research institutions, biotechnology companies, contract research organizations (CROs), and pharmaceutical companies, each emphasizing distinct performance and service requirements.
  • Applications: Diagnostics, research and development, and therapeutic solutions (including antibiotics, monoclonal antibodies, and vaccines).
  • Therapeutic Areas: Cardiovascular, immunology, infectious diseases, and oncology.
  • Regions: Americas (with detailed coverage in the United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including Western/Eastern Europe, Gulf, and African countries), and Asia-Pacific (featuring China, India, Japan, South Korea, Australia, Southeast Asian countries, and others).
  • Leading Companies: A strategic mix of established pharmaceutical firms, biotechnology innovators, and service providers, such as AbbVie, Amgen, AstraZeneca, Thermo Fisher Scientific, WuXi AppTec, and others.

Key Takeaways for Senior Decision-Makers

  • Pace of innovation is accelerating, with advances in bioconjugation chemistry, such as site-specific and bio-orthogonal methods, expanding clinical and research applications.
  • Macroeconomic shifts and policy changes—including evolving tariff structures—are influencing sourcing, pricing, and supply chain continuity.
  • Strategic alliances between reagent suppliers and contract research organizations enable streamlined solutions and more agile responses to market opportunities.
  • Regional differences in funding, regulatory regimes, and biopharma infrastructure shape adoption rates and commercialization timelines for bioconjugation products.
  • Application diversification, extending beyond therapeutics into diagnostics and R&D tools, is opening new revenue streams and facilitating broader market engagement.

Tariff Impact

Recent United States tariffs implemented in 2025 have increased complexity for bioconjugation supply chains, particularly affecting the cost and sourcing of internationally procured raw materials and specialized reagents. These measures drive some industry stakeholders to localize reagent manufacturing, reduce dependence on imports, and negotiate hybrid pricing models tied to raw material costs. Regional CROs capitalize on near-shore service offerings, but also manage capacity and regulatory hurdles tied to equipment scalability and approvals.

Methodology & Data Sources

This study integrates primary interviews with key industry opinion leaders and end users, complemented by proprietary surveys and a thorough review of scientific literature, patent filings, financial disclosures, and regulatory guidelines. Trade and clinical trial data inform scenario analyses and trend validation for a nuanced, data-driven view.

Why This Report Matters

  • Empowers leadership with actionable insights on segment momentum, competitive positioning, and regional opportunities, supporting strategic investment and resource allocation.
  • Delivers in-depth analysis of how technology, policy, and supply chain shifts impact bioconjugation innovation and commercialization.
  • Equips organizations to anticipate regulatory changes and tariff effects, mitigating risks and unlocking new growth avenues within the bioconjugation landscape.

Conclusion

This report provides a comprehensive foundation for informed strategic decision-making. By leveraging its insights, organizations can navigate evolving bioconjugation trends, enhance operational resilience, and drive market success in a rapidly changing global landscape.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Bioconjugation Market, by Bioconjugation Type
8.1. Introduction
8.2. Oligonucleotide Bioconjugation
8.2.1. Double-Stranded Oligonucleotides
8.2.2. Single-Stranded Oligonucleotides
8.3. Peptide Bioconjugation
8.4. Polymer Bioconjugation
8.5. Protein Bioconjugation
9. Bioconjugation Market, by Offering
9.1. Introduction
9.2. Reagents & Kits
9.3. Services
9.3.1. ADC Process Development
9.3.2. Analytical development
9.3.3. Drug Substance Manufacturing
9.3.4. Early Development Bioconjugate Services
9.3.5. Payload & Linker Manufacturing
9.3.6. Targeting Agent or Carrier Protein Services
10. Bioconjugation Market, by Technique
10.1. Introduction
10.2. Amide Bond Formation
10.3. Bio-orthogonal Reactions
10.4. Click Chemistry
10.5. Enzymatic Methods
10.6. Thiol-Maleimide Coupling
11. Bioconjugation Market, by Type
11.1. Introduction
11.2. Natural Bioconjugates
11.3. Synthetic Bioconjugates
12. Bioconjugation Market, by End User
12.1. Introduction
12.2. Academic & Research Institutions
12.3. Biotechnology Companies
12.4. Contract Research Organizations
12.5. Pharmaceutical Companies
13. Bioconjugation Market, by Applications
13.1. Introduction
13.2. Diagnostics
13.3. Research and Development
13.4. Therapeutic
13.4.1. Antibiotics
13.4.2. Monoclonal Antibodies
13.4.3. Vaccines
14. Bioconjugation Market, by Therapeutic Areas
14.1. Introduction
14.2. Cardiovascular Disorders
14.3. Immunology
14.4. Infectious Diseases
14.5. Oncology
15. Americas Bioconjugation Market
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. Argentina
16. Europe, Middle East & Africa Bioconjugation Market
16.1. Introduction
16.2. United Kingdom
16.3. Germany
16.4. France
16.5. Russia
16.6. Italy
16.7. Spain
16.8. United Arab Emirates
16.9. Saudi Arabia
16.10. South Africa
16.11. Denmark
16.12. Netherlands
16.13. Qatar
16.14. Finland
16.15. Sweden
16.16. Nigeria
16.17. Egypt
16.18. Turkey
16.19. Israel
16.20. Norway
16.21. Poland
16.22. Switzerland
17. Asia-Pacific Bioconjugation Market
17.1. Introduction
17.2. China
17.3. India
17.4. Japan
17.5. Australia
17.6. South Korea
17.7. Indonesia
17.8. Thailand
17.9. Philippines
17.10. Malaysia
17.11. Singapore
17.12. Vietnam
17.13. Taiwan
18. Competitive Landscape
18.1. Market Share Analysis, 2024
18.2. FPNV Positioning Matrix, 2024
18.3. Competitive Analysis
18.3.1. AbbVie Inc.
18.3.2. Abcam plc by Danaher Corporation
18.3.3. Abzena Limited
18.3.4. Agilent Technologies, Inc.
18.3.5. Amgen Inc.
18.3.6. AstraZeneca PLC
18.3.7. Bio-Techne Corporation
18.3.8. Biocon Limited
18.3.9. Boehringer Ingelheim GmbH
18.3.10. Bristol-Myers Squibb Company
18.3.11. Charles River Laboratories International, Inc.
18.3.12. Eli Lilly and Company
18.3.13. F. Hoffmann-La Roche AG
18.3.14. GlaxoSmithKline plc
18.3.15. Innovagen AB
18.3.16. Johnson & Johnson Services Inc
18.3.17. Lonza Group AG
18.3.18. Merck KGaA
18.3.19. Pfizer Inc.
18.3.20. Sanofi S.A.
18.3.21. Sartorius AG
18.3.22. Sorrento Therapeutics, Inc.
18.3.23. Sutro Biopharma, Inc.
18.3.24. Thermo Fisher Scientific Inc.
18.3.25. WuXi AppTec Co., Ltd
19. ResearchAI
20. ResearchStatistics
21. ResearchContacts
22. ResearchArticles
23. Appendix
List of Figures
FIGURE 1. BIOCONJUGATION MARKET MULTI-CURRENCY
FIGURE 2. BIOCONJUGATION MARKET MULTI-LANGUAGE
FIGURE 3. BIOCONJUGATION MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL BIOCONJUGATION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL BIOCONJUGATION MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BIOCONJUGATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BIOCONJUGATION MARKET SIZE, BY BIOCONJUGATION TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BIOCONJUGATION MARKET SIZE, BY BIOCONJUGATION TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BIOCONJUGATION MARKET SIZE, BY OFFERING, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BIOCONJUGATION MARKET SIZE, BY OFFERING, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BIOCONJUGATION MARKET SIZE, BY TECHNIQUE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BIOCONJUGATION MARKET SIZE, BY TECHNIQUE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BIOCONJUGATION MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BIOCONJUGATION MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL BIOCONJUGATION MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 16. GLOBAL BIOCONJUGATION MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL BIOCONJUGATION MARKET SIZE, BY APPLICATIONS, 2024 VS 2030 (%)
FIGURE 18. GLOBAL BIOCONJUGATION MARKET SIZE, BY APPLICATIONS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL BIOCONJUGATION MARKET SIZE, BY THERAPEUTIC AREAS, 2024 VS 2030 (%)
FIGURE 20. GLOBAL BIOCONJUGATION MARKET SIZE, BY THERAPEUTIC AREAS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. AMERICAS BIOCONJUGATION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. AMERICAS BIOCONJUGATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. UNITED STATES BIOCONJUGATION MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 24. UNITED STATES BIOCONJUGATION MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. EUROPE, MIDDLE EAST & AFRICA BIOCONJUGATION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. EUROPE, MIDDLE EAST & AFRICA BIOCONJUGATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. ASIA-PACIFIC BIOCONJUGATION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 28. ASIA-PACIFIC BIOCONJUGATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 29. BIOCONJUGATION MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 30. BIOCONJUGATION MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. BIOCONJUGATION MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BIOCONJUGATION MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BIOCONJUGATION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BIOCONJUGATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL BIOCONJUGATION MARKET SIZE, BY BIOCONJUGATION TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL BIOCONJUGATION MARKET SIZE, BY OLIGONUCLEOTIDE BIOCONJUGATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BIOCONJUGATION MARKET SIZE, BY DOUBLE-STRANDED OLIGONUCLEOTIDES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BIOCONJUGATION MARKET SIZE, BY SINGLE-STRANDED OLIGONUCLEOTIDES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BIOCONJUGATION MARKET SIZE, BY OLIGONUCLEOTIDE BIOCONJUGATION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BIOCONJUGATION MARKET SIZE, BY PEPTIDE BIOCONJUGATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BIOCONJUGATION MARKET SIZE, BY POLYMER BIOCONJUGATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BIOCONJUGATION MARKET SIZE, BY PROTEIN BIOCONJUGATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BIOCONJUGATION MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BIOCONJUGATION MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BIOCONJUGATION MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BIOCONJUGATION MARKET SIZE, BY ADC PROCESS DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BIOCONJUGATION MARKET SIZE, BY ANALYTICAL DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BIOCONJUGATION MARKET SIZE, BY DRUG SUBSTANCE MANUFACTURING, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BIOCONJUGATION MARKET SIZE, BY EARLY DEVELOPMENT BIOCONJUGATE SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BIOCONJUGATION MARKET SIZE, BY PAYLOAD & LINKER MANUFACTURING, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BIOCONJUGATION MARKET SIZE, BY TARGETING AGENT OR CARRIER PROTEIN SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BIOCONJUGATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL BIOCONJUGATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL BIOCONJUGATION MARKET SIZE, BY AMIDE BOND FORMATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL BIOCONJUGATION MARKET SIZE, BY BIO-ORTHOGONAL REACTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL BIOCONJUGATION MARKET SIZE, BY CLICK CHEMISTRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL BIOCONJUGATION MARKET SIZE, BY ENZYMATIC METHODS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL BIOCONJUGATION MARKET SIZE, BY THIOL-MALEIMIDE COUPLING, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL BIOCONJUGATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL BIOCONJUGATION MARKET SIZE, BY NATURAL BIOCONJUGATES, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL BIOCONJUGATION MARKET SIZE, BY SYNTHETIC BIOCONJUGATES, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL BIOCONJUGATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL BIOCONJUGATION MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL BIOCONJUGATION MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL BIOCONJUGATION MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL BIOCONJUGATION MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL BIOCONJUGATION MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL BIOCONJUGATION MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL BIOCONJUGATION MARKET SIZE, BY RESEARCH AND DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL BIOCONJUGATION MARKET SIZE, BY THERAPEUTIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL BIOCONJUGATION MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL BIOCONJUGATION MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL BIOCONJUGATION MARKET SIZE, BY VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL BIOCONJUGATION MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL BIOCONJUGATION MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL BIOCONJUGATION MARKET SIZE, BY CARDIOVASCULAR DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL BIOCONJUGATION MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL BIOCONJUGATION MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL BIOCONJUGATION MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS BIOCONJUGATION MARKET SIZE, BY BIOCONJUGATION TYPE, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS BIOCONJUGATION MARKET SIZE, BY OLIGONUCLEOTIDE BIOCONJUGATION, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS BIOCONJUGATION MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS BIOCONJUGATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS BIOCONJUGATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS BIOCONJUGATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS BIOCONJUGATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS BIOCONJUGATION MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS BIOCONJUGATION MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS BIOCONJUGATION MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS BIOCONJUGATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES BIOCONJUGATION MARKET SIZE, BY BIOCONJUGATION TYPE, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES BIOCONJUGATION MARKET SIZE, BY OLIGONUCLEOTIDE BIOCONJUGATION, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES BIOCONJUGATION MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES BIOCONJUGATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES BIOCONJUGATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 67. UNITED STATES BIOCONJUGATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 68. UNITED STATES BIOCONJUGATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 69. UNITED STATES BIOCONJUGATION MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 70. UNITED STATES BIOCONJUGATION MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 71. UNITED STATES BIOCONJUGATION MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES BIOCONJUGATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 73. CANADA BIOCONJUGATION MARKET SIZE, BY BIOCONJUGATION TYPE, 2018-2030 (USD MILLION)
TABLE 74. CANADA BIOCONJUGATION MARKET SIZE, BY OLIGONUCLEOTIDE BIOCONJUGATION, 2018-2030 (USD MILLION)
TABLE 75. CANADA BIOCONJUGATION MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 76. CANADA BIOCONJUGATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 77. CANADA BIOCONJUGATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 78. CANADA BIOCONJUGATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 79. CANADA BIOCONJUGATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 80. CANADA BIOCONJUGATION MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 81. CANADA BIOCONJUGATION MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 82. CANADA BIOCONJUGATION MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 83. MEXICO BIOCONJUGATION MARKET SIZE, BY BIOCONJUGATION TYPE, 2018-2030 (USD MILLION)
TABLE 84. MEXICO BIOCONJUGATION MARKET SIZE, BY OLIGONUCLEOTIDE BIOCONJUGATION, 2018-2030 (USD MILLION)
TABLE 85. MEXICO BIOCONJUGATION MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 86. MEXICO BIOCONJUGATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 87. MEXICO BIOCONJUGATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 88. MEXICO BIOCONJUGATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 89. MEXICO BIOCONJUGATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 90. MEXICO BIOCONJUGATION MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 91. MEXICO BIOCONJUGATION MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 92. MEXICO BIOCONJUGATION MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 93. BRAZIL BIOCONJUGATION MARKET SIZE, BY BIOCONJUGATION TYPE, 2018-2030 (USD MILLION)
TABLE 94. BRAZIL BIOCONJUGATION MARKET SIZE, BY OLIGONUCLEOTIDE BIOCONJUGATION, 2018-2030 (USD MILLION)
TABLE 95. BRAZIL BIOCONJUGATION MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 96. BRAZIL BIOCONJUGATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 97. BRAZIL BIOCONJUGATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 98. BRAZIL BIOCONJUGATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 99. BRAZIL BIOCONJUGATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 100. BRAZIL BIOCONJUGATION MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 101. BRAZIL BIOCONJUGATION MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 102. BRAZIL BIOCONJUGATION MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 103. ARGENTINA BIOCONJUGATION MARKET SIZE, BY BIOCONJUGATION TYPE, 2018-2030 (USD MILLION)
TABLE 104. ARGENTINA BIOCONJUGATION MARKET SIZE, BY OLIGONUCLEOTIDE BIOCONJUGATION, 2018-2030 (USD MILLION)
TABLE 105. ARGENTINA BIOCONJUGATION MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 106. ARGENTINA BIOCONJUGATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 107. ARGENTINA BIOCONJUGATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 108. ARGENTINA BIOCONJUGATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 109. ARGENTINA BIOCONJUGATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 110. ARGENTINA BIOCONJUGATION MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 111. ARGENTINA BIOCONJUGATION MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 112. ARGENTINA BIOCONJUGATION MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 113. EUROPE, MIDDLE EAST & AFRICA BIOCONJUGATION MARKET SIZE, BY BIOCONJUGATION TYPE, 2018-2030 (USD MILLION)
TABLE 114. EUROPE, MIDDLE EAST & AFRICA BIOCONJUGATION MARKET SIZE, BY OLIGONUCLEOTIDE BIOCONJUGATION, 2018-2030 (USD MILLION)
TABLE 115. EUROPE, MIDDLE EAST & AFRICA BIOCONJUGATION MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 116. EUROPE, MIDDLE EAST & AFRICA BIOCONJUGATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 117. EUROPE, MIDDLE EAST & AFRICA BIOCONJUGATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 118. EUROPE, MIDDLE EAST & AFRICA BIOCONJUGATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 119. EUROPE, MIDDLE EAST & AFRICA BIOCONJUGATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 120. EUROPE, MIDDLE EAST & AFRICA BIOCONJUGATION MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 121. EUROPE, MIDDLE EAST & AFRICA BIOCONJUGATION MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 122. EUROPE, MIDDLE EAST & AFRICA BIOCONJUGATION MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA BIOCONJUGATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 124. UNITED KINGDOM BIOCONJUGATION MARKET SIZE, BY BIOCONJUGATION TYPE, 2018-2030 (USD MILLION)
TABLE 125. UNITED KINGDOM BIOCONJUGATION MARKET SIZE, BY OLIGONUCLEOTIDE BIOCONJUGATION, 2018-2030 (USD MILLION)
TABLE 126. UNITED KINGDOM BIOCONJUGATION MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 127. UNITED KINGDOM BIOCONJUGATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 128. UNITED KINGDOM BIOCONJUGATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 129. UNITED KINGDOM BIOCONJUGATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 130. UNITED KINGDOM BIOCONJUGATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 131. UNITED KINGDOM BIOCONJUGATION MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 132. UNITED KINGDOM BIOCONJUGATION MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 133. UNITED KINGDOM BIOCONJUGATION MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 134. GERMANY BIOCONJUGATION MARKET SIZE, BY BIOCONJUGATION TYPE, 2018-2030 (USD MILLION)
TABLE 135. GERMANY BIOCONJUGATION MARKET SIZE, BY OLIGONUCLEOTIDE BIOCONJUGATION, 2018-2030 (USD MILLION)
TABLE 136. GERMANY BIOCONJUGATION MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 137. GERMANY BIOCONJUGATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 138. GERMANY BIOCONJUGATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 139. GERMANY BIOCONJUGATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 140. GERMANY BIOCONJUGATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 141. GERMANY BIOCONJUGATION MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 142. GERMANY BIOCONJUGATION MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 143. GERMANY BIOCONJUGATION MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 144. FRANCE BIOCONJUGATION MARKET SIZE, BY BIOCONJUGATION TYPE, 2018-2030 (USD MILLION)
TABLE 145. FRANCE BIOCONJUGATION MARKET SIZE, BY OLIGONUCLEOTIDE BIOCONJUGATION, 2018-2030 (USD MILLION)
TABLE 146. FRANCE BIOCONJUGATION MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 147. FRANCE BIOCONJUGATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 148. FRANCE BIOCONJUGATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 149. FRANCE BIOCONJUGATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 150. FRANCE BIOCONJUGATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 151. FRANCE BIOCONJUGATION MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 152. FRANCE BIOCONJUGATION MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 153. FRANCE BIOCONJUGATION MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 154. RUSSIA BIOCONJUGATION MARKET SIZE, BY BIOCONJUGATION TYPE, 2018-2030 (USD MILLION)
TABLE 155. RUSSIA BIOCONJUGATION MARKET SIZE, BY OLIGONUCLEOTIDE BIOCONJUGATION, 2018-2030 (USD MILLION)
TABLE 156. RUSSIA BIOCONJUGATION MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 157. RUSSIA BIOCONJUGATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 158. RUSSIA BIOCONJUGATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 159. RUSSIA BIOCONJUGATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 160. RUSSIA BIOCONJUGATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 161. RUSSIA BIOCONJUGATION MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 162. RUSSIA BIOCONJUGATION MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 163. RUSSIA BIOCONJUGATION MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 164. ITALY BIOCONJUGATION MARKET SIZE, BY BIOCONJUGATION TYPE, 2018-2030 (USD MILLION)
TABLE 165. ITALY BIOCONJUGATION MARKET SIZE, BY OLIGONUCLEOTIDE BIOCONJUGATION, 2018-2030 (USD MILLION)
TABLE 166. ITALY BIOCONJUGATION MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 167. ITALY BIOCONJUGATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 168. ITALY BIOCONJUGATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 169. ITALY BIOCONJUGATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 170. ITALY BIOCONJUGATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 171. ITALY BIOCONJUGATION MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 172. ITALY BIOCONJUGATION MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 173. ITALY BIOCONJUGATION MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 174. SPAIN BIOCONJUGATION MARKET SIZE, BY BIOCONJUGATION TYPE, 2018-2030 (USD MILLION)
TABLE 175. SPAIN BIOCONJUGATION MARKET SIZE, BY OLIGONUCLEOTIDE BIOCONJUGATION, 2018-2030 (USD MILLION)
TABLE 176. SPAIN BIOCONJUGATION MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 177. SPAIN BIOCONJUGATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 178. SPAIN BIOCONJUGATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 179. SPAIN BIOCONJUGATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 180. SPAIN BIOCONJUGATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 181. SPAIN BIOCONJUGATION MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 182. SPAIN BIOCONJUGATION MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 183. SPAIN BIOCONJUGATION MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 184. UNITED ARAB EMIRATES BIOCONJUGATION MARKET SIZE, BY BIOCONJUGATION TYPE, 2018-2030 (USD MILLION)
TABLE 185. UNITED ARAB EMIRATES BIOCONJUGATION MARKET SIZE, BY OLIGONUCLEOTIDE BIOCONJUGATION, 2018-2030 (USD MILLION)
TABLE 186. UNITED ARAB EMIRATES BIOCONJUGATION MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 187. UNITED ARAB EMIRATES BIOCONJUGATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 188. UNITED ARAB EMIRATES BIOCONJUGATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 189. UNITED ARAB EMIRATES BIOCONJUGATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 190. UNITED ARAB EMIRATES BIOCONJUGATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 191. UNITED ARAB EMIRATES BIOCONJUGATION MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 192. UNITED ARAB EMIRATES BIOCONJUGATION MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 193. UNITED ARAB EMIRATES BIOCONJUGATION MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 194. SAUDI ARABIA BIOCONJUGATION MARKET SIZE, BY BIOCONJUGATION TYPE, 2018-2030 (USD MILLION)
TABLE 195. SAUDI ARABIA BIOCONJUGATION MARKET SIZE, BY OLIGONUCLEOTIDE BIOCONJUGATION, 2018-2030 (USD MILLION)
TABLE 196. SAUDI ARABIA BIOCONJUGATION MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 197. SAUDI ARABIA BIOCONJUGATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 198. SAUDI ARABIA BIOCONJUGATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 199. SAUDI ARABIA BIOCONJUGATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 200. SAUDI ARABIA BIOCONJUGATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 201. SAUDI ARABIA BIOCONJUGATION MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 202. SAUDI ARABIA BIOCONJUGATION MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 203. SAUDI ARABIA BIOCONJUGATION MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 204. SOUTH AFRICA BIOCONJUGATION MARKET SIZE, BY BIOCONJUGATION TYPE, 2018-2030 (USD MILLION)
TABLE 205. SOUTH AFRICA BIOCONJUGATION MARKET SIZE, BY OLIGONUCLEOTIDE BIOCONJUGATION, 2018-2030 (USD MILLION)
TABLE 206. SOUTH AFRICA BIOCONJUGATION MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 207. SOUTH AFRICA BIOCONJUGATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 208. SOUTH AFRICA BIOCONJUGATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 209. SOUTH AFRICA BIOCONJUGATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 210. SOUTH AFRICA BIOCONJUGATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 211. SOUTH AFRICA BIOCONJUGATION MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 212. SOUTH AFRICA BIOCONJUGATION MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 213. SOUTH AFRICA BIOCONJUGATION MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 214. DENMARK BIOCONJUGATION MARKET SIZE, BY BIOCONJUGATION TYPE, 2018-2030 (USD MILLION)
TABLE 215. DENMARK BIOCONJUGATION MARKET SIZE, BY OLIGONUCLEOTIDE BIOCONJUGATION, 2018-2030 (USD MILLION)
TABLE 216. DENMARK BIOCONJUGATION MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 217. DENMARK BIOCONJUGATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 218. DENMARK BIOCONJUGATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 219. DENMARK BIOCONJUGATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 220. DENMARK BIOCONJUGATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 221. DENMARK BIOCONJUGATION MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 222. DENMARK BIOCONJUGATION MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 223. DENMARK BIOCONJUGATION MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 224. NETHERLANDS BIOCONJUGATION MARKET SIZE, BY BIOCONJUGATION TYPE, 2018-2030 (USD MILLION)
TABLE 225. NETHERLANDS BIOCONJUGATION MARKET SIZE, BY OLIGONUCLEOTIDE BIOCONJUGATION, 2018-2030 (USD MILLION)
TABLE 226. NETHERLANDS BIOCONJUGATION MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 227. NETHERLANDS BIOCONJUGATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 228. NETHERLANDS BIOCONJUGATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 229. NETHERLANDS BIOCONJUGATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 230. NETHERLANDS BIOCONJUGATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 231. NETHERLANDS BIOCONJUGATION MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 232. NETHERLANDS BIOCONJUGATION MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 233. NETHERLANDS BIOCONJUGATION MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 234. QATAR BIOCONJUGATION MARKET SIZE, BY BIOCONJUGATION TYPE, 2018-2030 (USD MILLION)
TABLE 235. QATAR BIOCONJUGATION MARKET SIZE, BY OLIGONUCLEOTIDE BIOCONJUGATION, 2018-2030 (USD MILLION)
TABLE 236. QATAR BIOCONJUGATION MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 237. QATAR BIOCONJUGATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 238. QATAR BIOCONJUGATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 239. QATAR BIOCONJUGATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 240. QATAR BIOCONJUGATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 241. QATAR BIOCONJUGATION MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 242. QATAR BIOCONJUGATION MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 243. QATAR BIOCONJUGATION MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 244. FINLAND BIOCONJUGATION MARKET SIZE, BY BIOCONJUGATION TYPE, 2018-2030 (USD MILLION)
TABLE 245. FINLAND BIOCONJUGATION MARKET SIZE, BY OLIGONUCLEOTIDE BIOCONJUGATION, 2018-2030 (USD MILLION)
TABLE 246. FINLAND BIOCONJUGATION MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 247. FINLAND BIOCONJUGATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 248. FINLAND BIOCONJUGATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 249. FINLAND BIOCONJUGATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 250. FINLAND BIOCONJUGATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 251. FINLAND BIOCONJUGATION MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 252. FINLAND BIOCONJUGATION MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 253. FINLAND BIOCONJUGATION MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 254. SWEDEN BIOCONJUGATION MARKET SIZE, BY BIOCONJUGATION TYPE, 2018-2030 (USD MILLION)
TABLE 255. SWEDEN BIOCONJUGATION MARKET SIZE, BY OLIGONUCLEOTIDE BIOCONJUGATION, 2018-2030 (USD MILLION)
TABLE 256. SWEDEN BIOCONJUGATION MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 257. SWEDEN BIOCONJUGATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 258. SWEDEN BIOCONJUGATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 259. SWEDEN BIOCONJUGATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 260. SWEDEN BIOCONJUGATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 261. SWEDEN BIOCONJUGATION MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 262. SWEDEN BIOCONJUGATION MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 263. SWEDEN BIOCONJUGATION MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 264. NIGERIA BIOCONJUGATION MARKET SIZE, BY BIOCONJUGATION TYPE, 2018-2030 (USD MILLION)
TABLE 265. NIGERIA BIOCONJUGATION MARKET SIZE, BY OLIGONUCLEOTIDE BIOCONJUGATION, 2018-2030 (USD MILLION)
TABLE 266. NIGERIA BIOCONJUGATION MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 267. NIGERIA BIOCONJUGATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 268. NIGERIA BIOCONJUGATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 269. NIGERIA BIOCONJUGATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 270. NIGERIA BIOCONJUGATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 271. NIGERIA BIOCONJUGATION MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 272. NIGERIA BIOCONJUGATION MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 273. NIGERIA BIOCONJUGATION MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 274. EGYPT BIOCONJUGATION MARKET SIZE, BY BIOCONJUGATION TYPE, 2018-2030 (USD MILLION)
TABLE 275. EGYPT BIOCONJUGATION MARKET SIZE, BY OLIGONUCLEOTIDE BIOCONJUGATION, 2018-2030 (USD MILLION)
TABLE 276. EGYPT BIOCONJUGATION MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 277. EGYPT BIOCONJUGATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 278. EGYPT BIOCONJUGATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 279. EGYPT BIOCONJUGATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 280. EGYPT BIOCONJUGATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 281. EGYPT BIOCONJUGATION MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 282. EGYPT BIOCONJUGATION MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 283. EGYPT BIOCONJUGATION MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 284. TURKEY BIOCONJUGATION MARKET SIZE, BY BIOCONJUGATION TYPE, 2018-2030 (USD MILLION)
TABLE 285. TURKEY BIOCONJUGATION MARKET SIZE, BY OLIGONUCLEOTIDE BIOCONJUGATION, 2018-2030 (USD MILLION)
TABLE 286. TURKEY BIOCONJUGATION MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 287. TURKEY BIOCONJUGATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 288. TURKEY BIOCONJUGATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 289. TURKEY BIOCONJUGATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 290. TURKEY BIOCONJUGATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 291. TURKEY BIOCONJUGATION MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 292. TURKEY BIOCONJUGATION MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 293. TURKEY BIOCONJUGATION MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 294. ISRAEL BIOCONJUGATION MARKET SIZE, BY BIOCONJUGATION TYPE, 2018-2030 (USD MILLION)
TABLE 295. ISRAEL BIOCONJUGATION MARKET SIZE, BY OLIGONUCLEOTIDE BIOCONJUGATION, 2018-2030 (USD MILLION)
TABLE 296. ISRAEL BIOCONJUGATION MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 297. ISRAEL BIOCONJUGATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 298. ISRAEL BIOCONJUGATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 299. ISRAEL BIOCONJUGATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 300. ISRAEL BIOCONJUGATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 301. ISRAEL BIOCONJUGATION MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 302. ISRAEL BIOCONJUGATION MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 303. ISRAEL BIOCONJUGATION MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 304. NORWAY BIOCONJUGATION MARKET SIZE, BY BIOCONJUGATION TYPE, 2018-2030 (USD MILLION)
TABLE 305. NORWAY BIOCONJUGATION MARKET SIZE, BY OLIGONUCLEOTIDE BIOCONJUGATION, 2018-2030 (USD MILLION)
TABLE 306. NORWAY BIOCONJUGATION MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 307. NORWAY BIOCONJUGATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 308. NORWAY BIOCONJUGATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 309. NORWAY BIOCONJUGATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 310. NORWAY BIOCONJUGATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 311. NORWAY BIOCONJUGATION MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 312. NORWAY BIOCONJUGATION MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 313. NORWAY BIOCONJUGATION MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 314. POLAND BIOCONJUGATION MARKET SIZE, BY BIOCONJUGATION TYPE, 2018-2030 (USD MILLION)
TABLE 315. POLAND BIOCONJUGATION MARKET SIZE, BY OLIGONUCLEOTIDE BIOCONJUGATION, 2018-2030 (USD MILLION)
TABLE 316. POLAND BIOCONJUGATION MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 317. POLAND BIOCONJUGATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 318. POLAND BIOCONJUGATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 319. POLAND BIOCONJUGATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 320. POLAND BIOCONJUGATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 321. POLAND BIOCONJUGATION MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 322. POLAND BIOCONJUGATION MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 323. POLAND BIOCONJUGATION MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 324. SWITZERLAND BIOCONJUGATION MARKET SIZE, BY BIOCONJUGATION TYPE, 2018-2030 (USD MILLION)
TABLE 325. SWITZERLAND BIOCONJUGATION MARKET SIZE, BY OLIGONUCLEOTIDE BIOCONJUGATION, 2018-2030 (USD MILLION)
TABLE 326. SWITZERLAND BIOCONJUGATION MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 327. SWITZERLAND BIOCONJUGATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 328. SWITZERLAND BIOCONJUGATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 329. SWITZERLAND BIOCONJUGATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 330. SWITZERLAND BIOCONJUGATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 331. SWITZERLAND BIOCONJUGATION MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 332. SWITZERLAND BIOCONJUGATION MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 333. SWITZERLAND BIOCONJUGATION MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 334. ASIA-PACIFIC BIOCONJUGATION MARKET SIZE, BY BIOCONJUGATION TYPE, 2018-2030 (USD MILLION)
TABLE 335. ASIA-PACIFIC BIOCONJUGATION MARKET SIZE, BY OLIGONUCLEOTIDE BIOCONJUGATION, 2018-2030 (USD MILLION)
TABLE 336. ASIA-PACIFIC BIOCONJUGATION MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 337. ASIA-PACIFIC BIOCONJUGATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 338. ASIA-PACIFIC BIOCONJUGATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 339. ASIA-PACIFIC BIOCONJUGATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 340. ASIA-PACIFIC BIOCONJUGATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 341. ASIA-PACIFIC BIOCONJUGATION MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 342. ASIA-PACIFIC BIOCONJUGATION MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 343. ASIA-PACIFIC BIOCONJUGATION MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 344. ASIA-PACIFIC BIOCONJUGATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 345. CHINA BIOCONJUGATION MARKET SIZE, BY BIOCONJUGATION TYPE, 2018-2030 (USD MILLION)
TABLE 346. CHINA BIOCONJUGATION MARKET SIZE, BY OLIGONUCLEOTIDE BIOCONJUGATION, 2018-2030 (USD MILLION)
TABLE 347. CHINA BIOCONJUGATION MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 348. CHINA BIOCONJUGATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 349. CHINA BIOCONJUGATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 350. CHINA BIOCONJUGATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 351. CHINA BIOCONJUGATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 352. CHINA BIOCONJUGATION MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 353. CHINA BIOCONJUGATION MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 354. CHINA BIOCONJUGATION MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 355. INDIA BIOCONJUGATION MARKET SIZE, BY BIOCONJUGATION TYPE, 2018-2030 (USD MILLION)
TABLE 356. INDIA BIOCONJUGATION MARKET SIZE, BY OLIGONUCLEOTIDE BIOCONJUGATION, 2018-2030 (USD MILLION)
TABLE 357. INDIA BIOCONJUGATION MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 358. INDIA BIOCONJUGATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 359. INDIA BIOCONJUGATION MARKE

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Bioconjugation market report include:
  • AbbVie Inc.
  • Abcam plc by Danaher Corporation
  • Abzena Limited
  • Agilent Technologies, Inc.
  • Amgen Inc.
  • AstraZeneca PLC
  • Bio-Techne Corporation
  • Biocon Limited
  • Boehringer Ingelheim GmbH
  • Bristol-Myers Squibb Company
  • Charles River Laboratories International, Inc.
  • Eli Lilly and Company
  • F. Hoffmann-La Roche AG
  • GlaxoSmithKline plc
  • Innovagen AB
  • Johnson & Johnson Services Inc
  • Lonza Group AG
  • Merck KGaA
  • Pfizer Inc.
  • Sanofi S.A.
  • Sartorius AG
  • Sorrento Therapeutics, Inc.
  • Sutro Biopharma, Inc.
  • Thermo Fisher Scientific Inc.
  • WuXi AppTec Co., Ltd

Table Information

Report AttributeDetails
No. of Pages189
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 10.12 Billion
Forecasted Market Value ( USD ) by 2030 $ 18.2 Billion
Compound Annual Growth Rate12.3%
Regions CoveredGlobal
No. of Companies Mentioned26

Related Topics

Related Reports

Bioconjugation Market Size, Share & Trends Analysis Report By Product & Services (Consumables, Instruments, Services), By Technique, By Biomolecule Type, By Application, By End Use, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Bioconjugation Market Size, Share & Trends Analysis Report By Product & Services (Consumables, Instruments, Services), By Technique, By Biomolecule Type, By Application, By End Use, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 120 Pages
  • Global
From
EUR$5,950USDGBP
Bioconjugation Market by Product (Consumables, Instruments (Chromatography, Spectrometry)), Service (Conjugation, Analytical), Technique (Chemical, Click Chemistry), Biomolecule (Antibodies), Application (Therapeutics (ADC), R&D) - Global Forecast to 2029 - Product Image

Bioconjugation Market by Product (Consumables, Instruments (Chromatography, Spectrometry)), Service (Conjugation, Analytical), Technique (Chemical, Click Chemistry), Biomolecule (Antibodies), Application (Therapeutics (ADC), R&D) - Global Forecast to 2029

  • Report
  • 683 Pages
  • Global
From
EUR$4,950USDGBP
Bioconjugation Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2020-2030F - Product Image

Bioconjugation Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2020-2030F

  • Report
  • 185 Pages
  • Global
From
EUR$3,825USDGBP
EUR$4,500USDGBP
Monoclonal Antibody Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Monoclonal Antibody Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 185 Pages
  • Global
From
EUR$3,825USDGBP
EUR$4,500USDGBP
Mammalian Polyclonal Immunoglobulin G (IgG) Antibody Market Report 2025 - Product Image

Mammalian Polyclonal Immunoglobulin G (IgG) Antibody Market Report 2025

  • Report
  • 200 Pages
  • Global
From
EUR$4,490USDGBP
Copyright © 2002-2025 Research and Markets. All Rights Reserved.
This website uses cookies to ensure you get the best experience. Learn more